• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GELESIS SRL PLENITY; DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GELESIS SRL PLENITY; DELIVERY SYSTEM Back to Search Results
Model Number MC0420
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
Colitis [colitis].Case narrative: this initial spontaneous report was received from the united states of america by a ro physician on (b)(6) 2022.A 68-year-old, female patient (weight: 235 lbs) experienced colitis while on plenity for weight management.The patient¿s current condition included hypothyroidism.No other medical history, drug allergies and usage of other medical devices were reported.The patient's concomitant medication included levothyroxine.On (b)(6) 2022, the patient started therapy with plenity at a dose of 0.75 gm, orally, twice daily for weight management.Lot number and expiry date of plenity were not reported.On an unknown date, the patient was hospitalized with colitis (pt: colitis) and discontinued plenity.On an unknown date, the event colitis was resolved.Action taken: patient discontinued plenity due to event colitis.Outcome of the event colitis was resolved.The case is assessed as serious due to the need for hospitalization.This case was verified by a healthcare professional.Company comment: this spontaneous report refers to a 68-year-old, female patient who experienced colitis while on plenity for weight management.The patient¿s current condition included hypothyroidism and concomitant medication included levothyroxine.The event colitis resulted in hospitalization following which plenity was discontinued and the symptoms resolved.The case is assessed as serious due to the need for hospitalization.Considering the reasonable temporal relationship, positive dechallenge, and spontaneous nature of the report, the causality is assessed as possible for the event colitis.More information regarding relevant medical history, details about the events leading to hospitalization, investigations done, and treatment provided is needed for a meaningful assessment of the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLENITY
Type of Device
DELIVERY SYSTEM
Manufacturer (Section D)
GELESIS SRL
via verdi, 188
calimera (le) 73021
IT  73021
Manufacturer (Section G)
GELESIS, INC.
501 boylston street, suite 610
2
boston MA 02116
Manufacturer Contact
via verdi, 188
calimera (le) 73021
MDR Report Key15216317
MDR Text Key297769942
Report Number3012121187-2022-00843
Device Sequence Number1
Product Code QFQ
Combination Product (y/n)N
PMA/PMN Number
DEN180060
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 08/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMC0420
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Treatment
LEVOTHYROXINE (LEVOTHYROXINE),
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexFemale
Patient Weight107 KG
-
-